Visual loss secondary to fludarabine toxicity: optical coherence tomography findings in two patients

[1]  G. Holder,et al.  Beneficial effects on vision in patients undergoing retinal gene therapy for choroideremia , 2018, Nature Medicine.

[2]  Adnan Tufail,et al.  Phase 1 clinical study of an embryonic stem cell–derived retinal pigment epithelium patch in age-related macular degeneration , 2018, Nature Biotechnology.

[3]  A. Cideciyan,et al.  Novel pathogenic mutations in C1QTNF5 support a dominant negative disease mechanism in late-onset retinal degeneration , 2017, Scientific Reports.

[4]  T. Porco,et al.  Incidence of Presumed Silicone Oil Droplets in the Vitreous Cavity After Intravitreal Bevacizumab Injection With Insulin Syringes , 2017, JAMA ophthalmology.

[5]  M. Leśniak,et al.  An investigation of the effect of silicone oil on polymer intraocular lenses by means of PALS, FT-IR and Raman spectroscopies. , 2016, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[6]  W. Friess,et al.  Analysis of thin baked-on silicone layers by FTIR and 3D-Laser Scanning Microscopy. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[7]  G. Illei,et al.  RAPID VISION LOSS ASSOCIATED WITH FLUDARABINE ADMINISTRATION , 2010, Retina.

[8]  A. McKinney,et al.  Clinical and imaging features of fludarabine neurotoxicity. , 2010, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[9]  A. Wright,et al.  Late-onset retinal macular degeneration: clinical insights into an inherited retinal degeneration , 2008, Postgraduate Medical Journal.

[10]  R. Bishop,et al.  Ocular toxicity of fludarabine: a purine analog , 2008, Expert review of ophthalmology.

[11]  A. Cideciyan,et al.  Mutation in a short-chain collagen gene, CTRP5, results in extracellular deposit formation in late-onset retinal degeneration: a genetic model for age-related macular degeneration. , 2003, Human molecular genetics.

[12]  B. Cheson,et al.  Treatment of refractory chronic lymphocytic leukemia with fludarabine phosphate via the group C protocol mechanism of the National Cancer Institute: five-year follow-up report. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  A. Cideciyan,et al.  Sub-retinal pigment epithelial deposits in a dominant late-onset retinal degeneration. , 1996, Investigative ophthalmology & visual science.

[14]  R. Warrell,et al.  Phase I and II study of fludarabine phosphate in leukemia: therapeutic efficacy with delayed central nervous system toxicity. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.